William J. Chase, EVP, Chief Financial Officer at AbbVie Inc. (ABBV), sold 13,821 shares at $50.19 ($711K) on 2014-03-03, disclosed to the SEC on 2014-03-04.
Scheduled sale ($711k) by EVP, Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $51.91 | 9,873 | $513K | 72.1% |
| 2 | $50.19 | 1,400 | $70K | 9.9% |
| 3 | $50.19 | 2,448 | $123K | 17.3% |
| 4 | $51.20 | 100 | $5K | 0.7% |
| Total | $51.43 avg | 13,821 | $711K | 100% |
| Filing → |
| ABBV | SELL | 2018-12-14 | $5.4M | — | Filing → |
| ABBV | SELL | 2018-03-02 | $12.9M | — | Filing → |
| ABBV | SELL | 2017-05-19 | $2.5M | — | Filing → |